rahul thakur·Jul 4Free Thiols, Broken BridgesRethinking Low-Molecular-Weight Impurities in Biologics Through PAT-Enabled Process Control
Riya Mukherjee, PhD, Biotechnology·Sep 21, 2025What makes biologics, such as extracellular vesicles, challenging to regulate?If small-molecule drugs are like Lego bricks, uniform, predictable, and easy to replicate, extracellular vesicles (EVs) are more like…
InZS AssociatesbyPrateek Yadav·Apr 14, 2024Pushing the generics button on the biosimilars contractingUnpacking alliances between biosimilar manufacturers and payers: A deep dive by ZS’s Biosimilars CoE
Biologics & Biosimilars Pipeline- Phase XS·Jan 29, 2020Monoclonal Antibodies Shaping the Dermatology Space!Biologics are the future of innovative therapeutics in dermatology. Various biologics such as monoclonal antibodies, recombinant human…
DCVC·Feb 14, 2019Reimagining biologics: AbCellera and Novartis partner to find new disease treatmentsThe companies are joining forces to find therapeutic antibodies for up to 10 target diseases.
